FGen and its ultra-high-throughput screening platform get acquired by Ginkgo Bioworks
16.03.2022
Ginkgo Bioworks, the leading horizontal platform for cell programming, today announced the entry into a definitive agreement to acquire FGen AG, a Swiss company specializing in strain development and optimization. FGen won Venture Kick stage 2 in 2010.
![]() FGen Team
|
Ginkgo and FGen plan to close the transaction promptly. Post-closing, Ginkgo expects that the integration of FGen's platform can greatly increase the capacity of Ginkgo's Design-Build-Test-Learn strain development engine, a foundation of Ginkgo's technology stack. By adding FGen's uHT screening platform to its existing HT screening systems, Ginkgo seeks to be able to routinely analyze the performance of millions of genetic prototypes in pooled format, upgrading the quality of candidate hits that feed into downstream workflows for strain characterization and validation. FGen's platform is extremely flexible across organisms, pathways, and target products. The platform can be deployed to screen for both intracellular and secreted target products as well as both small molecules and proteins. It can also accommodate diverse organisms including bacteria, yeast, filamentous species, and mammalian cells.
"Our team has spent the last decade building one of the most advanced screening platforms in the world in the hopes of enabling breakthrough discoveries and products across industries," said Andreas Meyer, Chief Executive Officer of FGen. "We are excited to be welcomed onto the Ginkgo platform where we can deploy this technology much more broadly and better support customers and their world-changing work."
Under the terms of the transaction, FGen will receive upfront payment and additional contingent consideration related to, among other things, the successful integration and deployment of the FGen technology across Ginkgo programs.
FGen won Venture Kick stage 2 in 2010.
Filamentous fungi with fluorescent stained cell walls grown in NLR
Source : Press Release Ginkgo Bioworks and pictures taken on FGen's website.

